Physician
Infectious Disease
Dr. Stephen A. Migueles, MD
Dr. Stephen A. Migueles practices Infectious Disease. Doctor Stephen A. Migueles, MD is a published physician. He published 51 publications, including: 'Primary cutaneous acanthamoeba infection in a patient with AIDS.'
Publications
- A subset of CD4/CD8 double negative T cells expresses HIV proteins in patients on ART.
- Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface.
- Increased Sequence Coverage through Combined Targeting of Variant and Conserved Epitopes Correlates with Control of HIV Replication.
- Evidence for innate immune system activation in HIV-1 infected elite controllers.
- Isolation of human monoclonal antibodies from peripheral blood B cells.
- Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization.
- Cytotoxic Capacity of SIV-Specific CD8(+) T Cells against Primary Autologous Targets Correlates with Immune Control in SIV-Infected Rhesus Macaques.
- Broad and potent neutralization of HIV-1 by a gp41-specific human antibody.
- Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials.
- Antibody-Dependent Cellular Cytotoxicity Against Primary HIV-Infected CD4+ T Cells is Directly Associated with the Magnitude of Surface IgG Binding.
- Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand.
- Qualitative features of the HIV-specific CD8+ T-cell response associated with immunologic control.
- CD4+ T Cells, Including Th17 and Cycling Subsets, are Intact in the Gut Mucosa of HIV-1 Infected Long-Term Non- Progressors.
- Correction: Elite Suppressors Harbor Low Levels of Integrated HIV DNA and High Levels of 2-LTR Circular HIV DNA Compared to HIV+ Patients On and Off HAART.
- Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles.
- Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV+ patients on and off HAART.
- Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV.
- Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables.
- Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy.
- Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenoty...
- Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies.
- Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals.
- Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control.
- Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infection.
- Broad HIV-1 neutralization mediated by CD4-binding site antibodies.
- CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro.
- HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.
- Qualitative host factors associated with immunological control of HIV infection by CD8 T cells.
- Quiescent phenotype of tumor-specific CD8+ T cells following immunization.
- The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration.
- Advances in understanding immunologic control of HIV infection.
- HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentation.
- T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis.
- Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogen...
- The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognit...
- Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells.
- HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.
- The Role of CD4(+) and CD8(+) T Cells in Controlling HIV Infection.
- Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired H...
- Gag-Positive Reservoir Cells Are Susceptible to HIV-Specific Cytotoxic T Lymphocyte Mediated Clearance.
- HIV/HCV-coinfected natural viral suppressors have better virologic responses to PEG-IFN and ribavirin than ARV-treated HIV/HCV patients.
- Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.
- Hyperadrenocorticism in a patient with esophageal squamous-cell carcinoma.
- Primary cutaneous acanthamoeba infection in a patient with AIDS.
- Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor...
- HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.
- Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors.
- Status of activation of circulating vaccine-elicited CD8+ T cells.
- Frequency and function of HIV-specific CD8(+) T cells.
- Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity param...
Schools
University of Miami School of Medicine
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Helpful Reviews
Similar Doctors
|
Dr. James V. Lawler, MD |
|
|
Dr. Mark R. Abbruzzese, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tyler E. Warkentien, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William B. Tauber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Todd D. Gleeson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip E. Coyne Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy H. Burgess, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. Koup, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Charu J. Mullick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shruthi Bellapu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David N. Burns, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nancy M. Ruiz, MD |
|
|
Sarah K. Browne
This Doctor is OpenDoctor Recommended.
|